Gadopentetate Dimeglumine
Selleck Chemicals
SKU:S4852-25MG
Couldn't load pickup availability
Gadopentetate Dimeglumine is a chelating reagent relevant to ion-sensitive and biochemical and cell-based models. It is especially relevant in biochemical and cell-based models, where defined compound exposure can be linked to metal-dependent biochemical and cellular responses.
As a chelating reagent, Gadopentetate Dimeglumine is suited to ion-sensitive assays in which metal availability influences biochemical or cellular outputs. That positioning is consistent with metal-dependent assay control and ion-sensitive biochemical experiments and with follow-up studies that compare concentration-dependent responses across orthogonal assay formats. When a fully resolved mechanism is unavailable, parallel readouts such as viability, reporter activity, morphology, localization, or biochemical conversion can still help position the compound experimentally.
Research Applications
- Metal-dependent assay control and ion-sensitive biochemical experiments
- Combination studies with orthogonal perturbagens
- Mechanism-oriented follow-up using biochemical and cellular endpoints
- Benchmarking of assay response across concentration ranges
Overall, Gadopentetate Dimeglumine is appropriate for ion-sensitive biochemical or cellular experiments in biochemical and cell-based models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- CAS No.:
- 86050-77-3
- Molecular Weight:
- 938
- Formula:
- C₁₄H₁₈GdN₃O₁₀·2C₇H₁₇NO₅·2H
- SMILES:
- CNCC(O)C(O)C(O)C(O)CO.CNCC(O)C(O)C(O)C(O)CO.OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.